KR20220168214A - Cosmetic composition for body cleanser containing turmeric - Google Patents
Cosmetic composition for body cleanser containing turmeric Download PDFInfo
- Publication number
- KR20220168214A KR20220168214A KR1020210077405A KR20210077405A KR20220168214A KR 20220168214 A KR20220168214 A KR 20220168214A KR 1020210077405 A KR1020210077405 A KR 1020210077405A KR 20210077405 A KR20210077405 A KR 20210077405A KR 20220168214 A KR20220168214 A KR 20220168214A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- turmeric
- cosmetic composition
- body cleanser
- skin
- Prior art date
Links
- 235000003373 curcuma longa Nutrition 0.000 title claims abstract description 79
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 239000002537 cosmetic Substances 0.000 title claims abstract description 52
- 235000003392 Curcuma domestica Nutrition 0.000 title claims description 49
- 235000013976 turmeric Nutrition 0.000 title claims description 49
- 244000008991 Curcuma longa Species 0.000 title claims 5
- 230000000694 effects Effects 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- 239000001215 curcuma longa l. root Substances 0.000 claims description 26
- 239000000843 powder Substances 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 11
- 238000001256 steam distillation Methods 0.000 claims description 10
- 238000004821 distillation Methods 0.000 claims description 5
- 238000000638 solvent extraction Methods 0.000 claims description 5
- 238000004299 exfoliation Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims 1
- 244000163122 Curcuma domestica Species 0.000 abstract description 48
- 230000003020 moisturizing effect Effects 0.000 abstract description 17
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 210000001732 sebaceous gland Anatomy 0.000 abstract description 3
- 230000006641 stabilisation Effects 0.000 abstract description 3
- 238000011105 stabilization Methods 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 238000005406 washing Methods 0.000 abstract 1
- 239000008513 turmeric extract Substances 0.000 description 13
- 235000020240 turmeric extract Nutrition 0.000 description 13
- 229940052016 turmeric extract Drugs 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000008213 purified water Substances 0.000 description 12
- 239000010681 turmeric oil Substances 0.000 description 12
- 239000000284 extract Substances 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000002454 curcuma longa l. root extract Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 229940008099 dimethicone Drugs 0.000 description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 102000011782 Keratins Human genes 0.000 description 5
- 108010076876 Keratins Proteins 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 5
- 241000241413 Propolis Species 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 229940069949 propolis Drugs 0.000 description 5
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 5
- 235000010234 sodium benzoate Nutrition 0.000 description 5
- 239000004299 sodium benzoate Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229940015975 1,2-hexanediol Drugs 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 4
- 230000003780 keratinization Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 210000002374 sebum Anatomy 0.000 description 4
- 229940031688 sodium c14-16 olefin sulfonate Drugs 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 3
- 206010012442 Dermatitis contact Diseases 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 3
- 241000366182 Melaleuca alternifolia Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 229930016183 alpha-curcumene Natural products 0.000 description 3
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- PHWISBHSBNDZDX-UHFFFAOYSA-N beta-Sesquiphellandrene Natural products CC(C)=CCCC(C)C1CCC(=C)C=C1 PHWISBHSBNDZDX-UHFFFAOYSA-N 0.000 description 3
- PHWISBHSBNDZDX-LSDHHAIUSA-N beta-sesquiphellandrene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CCC(=C)C=C1 PHWISBHSBNDZDX-LSDHHAIUSA-N 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- JIJQKFPGBBEJNF-UHFFFAOYSA-N curlone Chemical compound CC(C)=CC(=O)CC(C)C1CCC(=C)C=C1 JIJQKFPGBBEJNF-UHFFFAOYSA-N 0.000 description 3
- 229940079868 disodium laureth sulfosuccinate Drugs 0.000 description 3
- YGAXLGGEEQLLKV-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-2-sulfonatobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)CC(C([O-])=O)S([O-])(=O)=O YGAXLGGEEQLLKV-UHFFFAOYSA-L 0.000 description 3
- 229940100608 glycol distearate Drugs 0.000 description 3
- 229940094506 lauryl betaine Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229940095068 tetradecene Drugs 0.000 description 3
- XZRVRYFILCSYSP-OAHLLOKOSA-N (-)-beta-bisabolene Chemical compound CC(C)=CCCC(=C)[C@H]1CCC(C)=CC1 XZRVRYFILCSYSP-OAHLLOKOSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- NGDNVOAEIVQRFH-UHFFFAOYSA-N 2-nonanol Chemical compound CCCCCCCC(C)O NGDNVOAEIVQRFH-UHFFFAOYSA-N 0.000 description 2
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- ZMIQNSSHYBJKIL-UHFFFAOYSA-N Tumerone Chemical compound CC(C)=CC(=O)CC(C)C1=CC=C(C)CC1 ZMIQNSSHYBJKIL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- XOCANRBEOZQNAQ-KGLIPLIRSA-N ar-turmerone Natural products C[C@H](CC(=O)C=C(C)C)[C@@H]1CC=C(C)C=C1 XOCANRBEOZQNAQ-KGLIPLIRSA-N 0.000 description 2
- XZRVRYFILCSYSP-UHFFFAOYSA-N beta-Bisabolene Natural products CC(C)=CCCC(=C)C1CCC(C)=CC1 XZRVRYFILCSYSP-UHFFFAOYSA-N 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- IAQRGUVFOMOMEM-ONEGZZNKSA-N trans-but-2-ene Chemical compound C\C=C\C IAQRGUVFOMOMEM-ONEGZZNKSA-N 0.000 description 2
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 2
- 229930001895 zingiberene Natural products 0.000 description 2
- IAIHUHQCLTYTSF-QXFUBDJGSA-N (1s,3s,4r)-2,2,4-trimethylbicyclo[2.2.1]heptan-3-ol Chemical compound C1C[C@@]2(C)[C@H](O)C(C)(C)[C@@H]1C2 IAIHUHQCLTYTSF-QXFUBDJGSA-N 0.000 description 1
- KTRUDBISMBUJPW-UHFFFAOYSA-N 1-methyl-4-(6-methylhepta-1,5-dien-2-yl)cyclohexene Chemical compound CC(C)=CCCC(=C)C1CCC(C)=CC1.CC(C)=CCCC(=C)C1CCC(C)=CC1 KTRUDBISMBUJPW-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 244000186654 Fockea angustifolia Species 0.000 description 1
- 235000015210 Fockea angustifolia Nutrition 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- MOYAFQVGZZPNRA-UHFFFAOYSA-N alpha-Terpinolene Natural products CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000004920 epithelial cell of skin Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- JPCBEVHCIJLZFV-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO.CCCCC(O)CO JPCBEVHCIJLZFV-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 208000001875 irritant dermatitis Diseases 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- -1 softener Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 울금을 포함하는 바디클렌저용 화장료 조성물에 관한 것으로, 특히, 바디클렌저 조성물에 울금 분말 및 울금 뿌리수 추출물의 유효성분을 함유하여 피부의 보습성을 향상시킬 수 있는 바디클렌저용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for body cleanser containing turmeric, and in particular, to a cosmetic composition for body cleanser that can improve skin moisturizing properties by containing active ingredients of turmeric powder and turmeric root extract in the body cleanser composition. it's about
사람의 피부는 모공을 통하여 피지가 피부 표면으로 배출되고 분해됨으로써, 피부의 수분 증발을 억제하고 탄력을 유지한다. 이 때문에 피부 상피 세포의 비정상적인 각화는 모공을 막아 피지의 피부 표면 배출을 저해하여 공기 중의 미생물들이 피부표면에 번식하고 피지를 산패시킴으로써 피부 트러블의 요인이 되게 한다.Human skin suppresses moisture evaporation and maintains elasticity of the skin by discharging and decomposing sebum to the skin surface through pores. Because of this, abnormal keratinization of skin epithelial cells clogs pores and inhibits the discharge of sebum to the skin surface, causing microorganisms in the air to propagate on the skin surface and cause sebum to become rancid, causing skin trouble.
이러한 피부 트러블을 예방하기 위한 목적으로 하기 문헌 표시와 같은 바디클렌저를 사용하여 피부 트러블의 요인을 방지하기도 하는데, 바디클렌저는 피부표면의 노폐물을 깨끗이 제거하여 청결하고 건강하게 유지시켜주는 세정제이다. 세정제는 적은 양으로도 기포 발생 정도와 양이 우수하면서 사용시 표면 감촉이 매끄럽고, 피지 제거능 및 보습력이 뛰어나며, 물성의 안정성이 우수하고 저자극성인 것이 바람직하다.For the purpose of preventing such skin troubles, a body cleanser such as the one shown in the following literature is used to prevent skin trouble factors. It is preferable that the detergent is excellent in the degree and amount of bubble generation even in a small amount, has a smooth surface feel when used, excellent sebum removal ability and moisturizing power, excellent stability of physical properties, and hypoallergenicity.
따라서, 바디클렌저가 갖추어야 할 조건은 사용시 기포 발생 정도가 우수하고, 표면 감촉이 매끄러우며, 피부 흡수가 뛰어나야 하는 것은 물론, 사용 전후에 피부 자극이 없어야 하고, 항균력이 있어야 하며, 피부의 보습성을 장시간 유지할 수 있어야 한다.Therefore, the conditions that a body cleanser should have are excellent bubble generation, smooth surface feel, excellent skin absorption, no skin irritation before and after use, antibacterial power, and skin moisturizing properties. It should be able to hold for a long time.
본 출원인은 바디클렌저용 화장료 조성물에 대하여 연구하던 중 세정력이 우수하면서도 피부의 보습성을 장시간 유지할 수 있는 울금을 포함하는 바디클렌저용 화장료 조성물을 개발하게 되었다.While researching cosmetic compositions for body cleansers, the present applicant developed a cosmetic composition for body cleansers containing turmeric, which has excellent cleansing power and can maintain skin moisture for a long time.
본 발명이 해결하고자 하는 과제는, 종래의 보습력을 갖는 바디클렌저용 화장료 조성물을 개선 및 보완하고 다양한 추가 장점을 제공하는 데 있다.The problem to be solved by the present invention is to improve and supplement conventional cosmetic compositions for body cleansers having moisturizing power and to provide various additional advantages.
또한, 울금이 포함됨으로써, 향상된 피부 보습력을 갖는 것은 물론, 각제제거 및 항균 효과가 우수한 바디클렌저용 화장료 조성물을 제공하는 데 그 목적이 있다.In addition, by including turmeric, the object is to provide a cosmetic composition for body cleanser that has improved skin moisturizing power as well as excellent exfoliation and antibacterial effects.
본 발명은 울금을 포함하는 바디클렌저용 화장료 조성물이다.The present invention is a cosmetic composition for body cleanser containing turmeric.
상기 울금은, 울금 분말 및 울금 뿌리수일 수 있다.The turmeric may be turmeric powder and turmeric root water.
상기 조성물은, 전체 조성물 100 중량%를 기준으로, 울금 분말 0.15~0.25 중량% 및 울금 뿌리수 3~5 중량%를 포함할 수 있다.The composition may include 0.15 to 0.25% by weight of turmeric powder and 3 to 5% by weight of turmeric root water based on 100% by weight of the total composition.
상기 울금 뿌리수는, 용매추출(Solvent extraction), 증류(Hydrodistillation) 및 수증기 증류(Steam distillation) 중 선택된 어느 하나의 방법으로 추출한 후 분리하여 수득될 수 있다.The turmeric root water may be obtained by separating after extraction by any one method selected from solvent extraction, distillation, and steam distillation.
상기 울금 뿌리수는, 수증기 증류법으로 제조된 것일 수 있다.The turmeric root water may be prepared by steam distillation.
상기 조성물은, 25~48 %의 수분 증진 및 70 % 이상의 각질 제거효과를 발휘할 수 있다.The composition may exhibit an effect of increasing moisture by 25 to 48% and removing keratin by 70% or more.
본 발명의 울금을 포함하는 바디클렌저용 화장료 조성물은 울금의 유효성분을 포함함으로써, 피부 세정시 각질제거 효과를 갖는 것은 물론, 노화방지 효과 및 피지선 안정화가 지속적으로 도모되어 피부 보습력을 향상시킬 수 있는 효과가 있다.The cosmetic composition for body cleanser containing turmeric of the present invention contains an active ingredient of turmeric, so that it has an exfoliating effect during skin cleansing, as well as an anti-aging effect and sebaceous gland stabilization, which can improve skin moisturizing power. It works.
도 1은 울금 추출물로부터 울금 뿌리수 및 울금 오일을 제조하는 과정을 나타낸 것이다.
도 2A 및 도 2B는 바디클렌저용 화장료 조성물을 사용한 후 피부 수분 변화 및 피부 수분 개선율을 나타낸 것이다.
도 3A 내지 도 3E는 바디클렌저용 화장료 조성물의 사용후 피부 각질도 변화 및 개선도를 나타낸 것이다.1 shows a process for preparing turmeric root water and turmeric oil from turmeric extract.
Figures 2A and 2B show the skin moisture change and skin moisture improvement rate after using the cosmetic composition for body cleanser.
Figures 3A to 3E show the change and improvement of skin keratinization after use of the cosmetic composition for body cleanser.
이하, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시예에 대하여 첨부한 도면을 참고로 하여 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다. Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings so that those skilled in the art can easily carry out the present invention. However, the present invention may be embodied in many different forms and is not limited to the embodiments described herein.
본 발명의 목적은 종래의 보습력을 갖는 바디클렌저용 화장료 조성물을 개선 및 보완하고 다양한 추가 장점을 제공하는 데 있다. 또한, 울금이 포함됨으로써, 향상된 피부 보습력을 갖는 것은 물론, 각제제거 및 항균 효과가 우수한 바디클렌저용 화장료 조성물을 제공하는 데 그 목적이 있다.An object of the present invention is to improve and supplement conventional cosmetic compositions for body cleansers having moisturizing power and to provide various additional advantages. In addition, by including turmeric, the object is to provide a cosmetic composition for body cleanser that has improved skin moisturizing power as well as excellent exfoliation and antibacterial effects.
본 발명은 상기한 목적을 달성하기 위하여, 울금을 포함하는 바디클렌저용 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic composition for body cleanser containing turmeric.
상기 울금은 생강과의 식물로 울금(Curcuma longa Radix), 온울금(C aromatica), 서아출(C kwangsiensis) 및 봉아출(C zedoaria)을 포함한다. 특이한 냄새와 자극성이 있으며, 맛은 맵고 쓰다. 상기 울금은 혈액순환을 도와 생리통, 생리 불순, 옆구리 통증을 완화시키는 효과가 있다. 또한, 토혈, 코피, 피오줌을 치료하는 데에도 효능이 있으며, 정신을 맑게 하고 흉복부가 그득한 것을 없애주므로 담즙 분비 촉진과 담낭 결석 치료에도 쓰일 수 있다. 상기 울금의 약리작용은 담즙분비, 배설 촉진, 관상동맥 안의 반괴 형성을 감소시킨다.The turmeric is a plant of the ginger family and includes turmeric (Curcuma longa Radix), turmeric (C aromatica), C kwangsiensis, and C zedoaria. It has a peculiar smell and irritation, and the taste is spicy and bitter. The turmeric has the effect of relieving menstrual cramps, menstrual irregularities, and flank pain by helping blood circulation. In addition, it is effective in treating hematemesis, nosebleeds, and blood urine, and it clears the mind and removes the fullness of the chest and abdomen, so it can be used to promote bile secretion and treat gallbladder stones. The pharmacological action of turmeric is to promote bile secretion, excretion, and reduce plaque formation in the coronary arteries.
본 발명에서 상기 울금은, 울금 분말 및 울금 추출물일 수 있으며, 상기 울금 추출물은 울금 뿌리수일 수 있다.In the present invention, the turmeric may be turmeric powder and turmeric extract, and the turmeric extract may be turmeric root water.
상기 울금 뿌리수는 용매추출(Solvent extraction), 증류(Hydrodistillation) 및 수증기 증류(Steam distillation) 중 선택된 어느 하나의 방법을 사용하여 추출한 후 분리하여 수득되는 것일 수 있으며, 본 발명에서는 수증기 증류법을 사용하였다.The turmeric root water may be obtained by separating and extracting using any one method selected from solvent extraction, distillation, and steam distillation, and in the present invention, steam distillation was used .
상기 용매추출(Solvent extraction)은 용매를 이용하여 식물의 방향성 유효 성분을 녹여내고 용매를 다시 분리하여 유효 성분만을 얻는 방법이다.The solvent extraction is a method of obtaining only the active ingredient by dissolving the aromatic active ingredient of the plant using a solvent and separating the solvent again.
상기 용매추출에 사용되는 상기 용매는 정제수, 메탄올(Methanol), 에탄올(Ethanol), 프로판올(Propanol), 이소프로판올(Isopropanol), 부탄올(Butanol), 아세톤(Acetone), 글리세린(Glycerin), 프로필렌글리콜(Propylene glycol), 1,3-부틸렌글리콜(1,3-Butylene glycol), 메틸아세테이트(Methyl acetate), 에텔아세테이트(Ethyl acetate), 헥산(Hexane), 디에틸에테르(Diethylether), 디클로로메탄(Dichloromethane) 및 소르비톨(Sorbitol)로 이루어진 군 중 선택된 1 종 이상의 것일 수 있다.The solvent used for the solvent extraction is purified water, methanol, ethanol, propanol, isopropanol, butanol, acetone, glycerin, propylene glycol glycol), 1,3-Butylene glycol, Methyl acetate, Ethyl acetate, Hexane, Diethylether, Dichloromethane And it may be at least one selected from the group consisting of sorbitol.
상기 증류(Hydrodistillation) 및 상기 수증기 증류(Steam distillation)는 모두 증기를 이용하여 추출하는 방법으로, 상기 수증기 증류는 끓는점이 높고, 물에 거의 녹지 않는 유기화합물에 수증기를 불어넣어, 그 물질의 끓는점보다 낮은 온도에서 수증기와 함께 유출되어 나오는 물질의 증기를 냉각하여, 물과의 혼합물로서 응축시키고 그것을 분리시키는 증류법이다.Both the hydrodistillation and the steam distillation are extraction methods using steam. Distillation is a method of distillation in which the vapor of a substance that comes out with water vapor is cooled at a low temperature, condensed as a mixture with water, and separated.
상기 울금 추출물 및 울금 뿌리수의 제조방법은 하기에서 설명하도록 한다.The method for preparing the turmeric extract and turmeric root water will be described below.
상기 울금 분말은 세포 독성을 증강시키며, 뇌 신경 세포의 치유를 촉진하고, 염증, 통증완화, 혈관치료, 항염증, 진정효과, 면역을 촉진하는 효과가 있으며, 상기 울금 분말은 주요 성분으로 상기 울금 분말 100 중량% 기준으로 진지베린(Zingiberene) 36.734 중량%, 베타-세스퀴펠린드렌(β-Sesquiphellandrene) 20.938 중량%, 투메론(Tumerone) 8.713 중량%, 알파-쿠르쿠멘(α-Curcumene) 7.376 중량%, 베타-비사볼렌(β-Bisabolene) 4.937 중량%, 베타-튜메론(β-Turmerone) 3.250 중량%를 포함할 수 있다.The turmeric powder enhances cytotoxicity, promotes healing of brain nerve cells, has the effect of relieving inflammation, pain relief, blood vessel treatment, anti-inflammatory, soothing effect, and promoting immunity, and the turmeric powder is the main component of the turmeric. Based on 100% by weight of powder, 36.734% by weight of Zingiberene, 20.938% by weight of beta-sesquiphellandrene, 8.713% by weight of Tumerone, 7.376% by weight of α-Curcumene %, beta-bisabolene (β-Bisabolene) 4.937% by weight, beta-turmerone (β-Turmerone) 3.250% by weight.
상기 울금 뿌리수는 항염증, 보혈, 면역촉진, 진정작용 및 세포 독성 증강 효과가 있으며, 상기 울금 뿌리수는 주요 성분으로, 상기 울금 뿌리수 100 중량% 기준으로 유칼리프톨(Ekucalyptol) 37.647 중량%, 베타-세크퀴펠린드렌(β-Sesquiphellandrene) 11.367 중량%, 베타-비사볼렌(β-Bisabolene) 10.992 중량%, 노난올(2-Nonanol) 8.233 중량%, 알파-쿠르쿠멘(α-Curcumene) 5.030 중량%, 베타-펜콜 알코올(β-Fenchyl alcohol) 4.946 중량% 및 베타-튜메론(β-Turmerone) 2.615 중량%를 포함할 수 있다.The turmeric root water has anti-inflammatory, blood-stimulating, immunostimulating, sedative and cytotoxicity enhancing effects, and the turmeric root water is a main component, 37.647% by weight of eucalyptol based on 100% by weight of the turmeric root water. , β-Sesquiphellandrene 11.367% by weight, β-Bisabolene 10.992% by weight, 2-Nonanol 8.233% by weight, α-Curcumene 5.030 % by weight, 4.946% by weight of β-Fenchyl alcohol and 2.615% by weight of β-Turmerone.
본 발명의 울금을 포함하는 바디클렌저용 화장료 조성물은 전체 조성물 100 중량%를 기준으로, 울금 분말 0.15~0.25 중량% 및 울금 뿌리수 3~5 중량%를 포함할 수 있으며, 바람직하게는 울금 분말 0.2 중량% 및 울금 뿌리수 4.5 중량%를 포함할 수 있다.The cosmetic composition for body cleanser containing turmeric of the present invention may include 0.15 to 0.25% by weight of turmeric powder and 3 to 5% by weight of turmeric root water, based on 100% by weight of the total composition, preferably 0.2% by weight of turmeric powder. % by weight and 4.5% by weight of turmeric root water.
상기 울금 분말의 함량이 0.15 중량% 미만이면, 기대치에 미치는 울금의 항균 효과를 발휘할 수 없으며, 최종 제품의 색상이 연하여 기호도가 저하되는 문제점이 있고, 0.25 중량%를 초과하면, 원료간 혼합시 균질화되지 않으며, 색상이 진하여 기호도가 저하되는 문제점이 있어, 상기한 범위가 바람직하다.If the content of the turmeric powder is less than 0.15% by weight, the expected antibacterial effect of turmeric cannot be exerted, and the color of the final product is pale, resulting in a decrease in preference, and if it exceeds 0.25% by weight, when mixing between raw materials It is not homogenized, and there is a problem that the color is dark and the preference is lowered, so the above range is preferable.
또한, 상기 울금 뿌리수의 함량이 3 중량% 미만이면, 보습 효과 및 사용감 낮은 문제점이 있고, 5 중량%를 초과하면, 울금 특위의 향이 강하여 기호도가 낮어지는 문제점이 있어, 상기한 범위가 바람직하다.In addition, if the content of the turmeric root water is less than 3% by weight, there is a problem of moisturizing effect and low feeling of use, and if it exceeds 5% by weight, there is a problem that the taste of turmeric is strong and the degree of preference is lowered, and the above range is preferable. .
따라서, 본 발명의 울금을 포함하는 바디클렌저 화장료 조성물은 전체 조성물 100 중량%를 기준으로 울금 분말 0.2 중량% 및 울금 뿌리수 4.5 중량%를 포함할 때 가장 우수한 수분 보습 및 각질제거 효과를 발휘할 수 있다.Therefore, the body cleanser cosmetic composition containing turmeric of the present invention can exhibit the best moisturizing and exfoliating effects when it contains 0.2% by weight of turmeric powder and 4.5% by weight of turmeric root water based on 100% by weight of the total composition. .
본 발명은 바디클렌저용 화장료 조성물에 항균효과를 부여하기 위하여, 전체 조성물 100 중량%를 기준으로, 울금 오일 0.0001~0.0003 중량%를 포함할 수 있다.The present invention may include 0.0001 to 0.0003% by weight of turmeric oil based on 100% by weight of the total composition in order to impart an antibacterial effect to the cosmetic composition for body cleanser.
상기 울금 오일의 함량이 0.0001 중량% 미만이면, 보습 및 향균 효과를 발휘하지 못하는 문제점이 있고, 0.0003 중량%를 초과하면, 투입량 대비 기대 효과에 못미치며, 최종 제품의 단가가 상승하여 경제적이지 못한 문제점이 있어 상기한 범위가 바람직하다.If the content of the turmeric oil is less than 0.0001% by weight, there is a problem of not exhibiting moisturizing and antibacterial effects, and if it exceeds 0.0003% by weight, the expected effect compared to the input amount is not met, and the unit price of the final product rises, which is uneconomical. Because of this, the above range is preferable.
상기 울금 오일은 항염 및 항균 효과가 있고, 혈관 강화, 콜레스테롤, 고혈압, 심근경색, 뇌졸증 개선 및 노화억제 효과가 있으며, 뇌 신경 세포의 치유를 촉진하고, 염증, 통증완화 및 혈관치료 효과가 있으며, 상기 울금 오일은 주요 성분으로, 상기 울금 오일 100 중량% 기준으로 진지베리(Zingiberene) 28.467 중량%, 베타-세크퀴펠린드렌(β-Sesquiphellandrene) 17.988 중량%, 유칼리프톨(Eucalyptol) 6.742 중량%, 알파-쿠르쿠멘(α-Curcumene) 5.573 중량%, 알파-(α-Terpinolene) 5.362 중량%, (β-Bisabolene) 4.025 중량%, 투메론(Tumerone) 3.917 중량%를 포함할 수 있다.The turmeric oil has anti-inflammatory and antibacterial effects, improves blood vessel strengthening, cholesterol, high blood pressure, myocardial infarction, stroke, and inhibits aging, promotes the healing of brain nerve cells, and has the effect of relieving inflammation, pain, and blood vessel treatment, The turmeric oil is a main component, based on 100% by weight of the turmeric oil, 28.467% by weight of Zingiberene, 17.988% by weight of β-Sesquiphellandrene, 6.742% by weight of Eucalyptol, 5.573% by weight of alpha-Curcumene, 5.362% by weight of alpha-(α-Terpinolene), 4.025% by weight of (β-Bisabolene), and 3.917% by weight of Tumerone.
도 1은 울금 추출물로부터 울금 뿌리수 및 울금 오일을 제조하는 과정을 나타낸 것이다.1 shows a process for preparing turmeric root water and turmeric oil from turmeric extract.
상기 울금 분말 및 울금 추출물의 제조방법에 대하여 간단하게 설명하면, 상기 울금 분말은 울금을 세절하는 단계, 숙성하는 단계, 건조하는 단계 및 분쇄하는 단계를 통해 제조될 수 있으며, 이는 통상의 기술이므로, 이에 대한 설명은 생략한다.Briefly explaining the method for producing the turmeric powder and turmeric extract, the turmeric powder can be prepared through the steps of cutting turmeric, aging, drying and grinding, which is a common technique. , the description thereof is omitted.
본 발명에서 상기 울금 추출물은 수증기 증류법을 통해 제조하였다. 상기 수증기 증류법을 통해 울금 추출물을 제조하면, 상기 울금 추출물은 수성 성분 및 유성 성분이 추출되는데 이를 분리하여 상기 울금 오일 및 상기 울금 뿌리수를 제조할 수 있다.In the present invention, the turmeric extract was prepared through steam distillation. When the turmeric extract is prepared through the steam distillation method, the turmeric extract has an aqueous component and an oily component extracted, and the turmeric oil and the turmeric root water can be prepared by separating them.
본 발명에서 상기 울금 뿌리수는 상기 울금 추출물에서 분리된 수성 성분 88 중량%, 1,3 부틸렌 글리콜(Butylene Glycol) 10 중량% 및 1,2 헥산디올(Hexanediol) 2 중량%를 혼합하여 혼합액을 제조하고, 이를 제균하는 과정을 통해 제조된다.In the present invention, the turmeric root water is obtained by mixing 88% by weight of the aqueous component separated from the turmeric extract, 10% by weight of 1,3 butylene glycol, and 2% by weight of 1,2 hexanediol to obtain a mixed solution It is produced through the process of manufacturing and disinfecting it.
상기 과정을 통해 화장료 조성물에 사용될 수 있도록 원료화된다.Through the above process, it is converted into a raw material so that it can be used in a cosmetic composition.
본 발명에서 울금 오일은 상기 울금 추출물에서 분리된 유성 성분 2 중량%, 글리세린(Glycerin) 66 중량%, 디메티콘(Diemethicone) 18 중량% 수첨 레시틴(Hydrogenated lecithin) 4 중량% 및 증류수 10 중량%를 70~80 ℃의 온도에서 혼합하여 혼합물을 제조하고 이를 고압균질기를 이용하여 균질화하는 과정을 통해 제조된다.In the present invention, turmeric oil is 70% by weight of 2% by weight of the oily component separated from the turmeric extract, 66% by weight of glycerin, 18% by weight of dimethicone, 4% by weight of hydrogenated lecithin and 10% by weight of distilled water It is prepared by mixing at a temperature of ~ 80 ° C. to prepare a mixture and homogenizing it using a high-pressure homogenizer.
상기 과정을 통해 상기 울금 오일은 화장료 조성물로 사용될 수 있도록 원료화된다.Through the above process, the turmeric oil is made into a raw material so that it can be used as a cosmetic composition.
본 발명에서 상기 바디클렌저용 화장료 조성물은, 정제수, 계면활성제, 유연제, 보습제, 보습제, 각젤제거제 산화방지제, 부형제 및 향료 등을 더 포함할 수 있으며, 구체적으로, 정제수, 소듐C14-16올레핀설포네이트(Sodium C14-16 olefin sulfonate), 코코-베타인(Coco-betaine), 글리세린(Glycerin), 소듐클로라이드(Sodium chloride), 부틸렌글라이콜(Butylene glycol), 글라이콜다이스테아레이트(Glycol distearate), 다이소듐라우레스설포석시네이트(Disodium laureth sulfosuccinate), 우레아(Urea), 하이드록시아세토페논(Hydroxyacetophenone), 테트라데센(Tetradecene), 라우릴베타인(Lauryl betaine), 헥사데센(Hexadecene), 1,2-헥사다이올(1,2-Hexanediol), 시트릭애씨드(Citri acid), 베타인(Betaine), 소듐벤조에이트(Sodium benzoate), 티트리추출물(Melaleuca alternifolia extract), 프로폴리스추출물(Propolis extract), 다이메디콘(Dimethicone), 소듐하이알루로네이트(Sodium hyaluronate), 하이드로제네이티드레시틴(Hydrogenated lecithin) 및 향료(Fragrance) 등을 더 포함할 수 있다.In the present invention, the cosmetic composition for body cleanser may further include purified water, surfactant, softener, moisturizer, moisturizer, keratin gel remover, antioxidant, excipient and fragrance, etc. Specifically, purified water, sodium C14-16 olefin sulfonate (Sodium C14-16 olefin sulfonate), Coco-betaine, Glycerin, Sodium chloride, Butylene glycol, Glycol distearate , Disodium laureth sulfosuccinate, Urea, Hydroxyacetophenone, Tetradecene, Lauryl betaine, Hexadecene, 1 ,2-Hexanediol (1,2-Hexanediol), Citric acid, Betaine, Sodium benzoate, Melaleuca alternifolia extract, Propolis extract extract), dimethicone, sodium hyaluronate, hydrogenated lecithin, fragrance, and the like may be further included.
본 발명에 따른 바디클렌저용 화장료 조성물은 25~48 %의 보습증진 효과를 발휘할 수 있으며, 70 % 이상의 각질제거 효과를 발휘할 수 있다.The cosmetic composition for body cleanser according to the present invention can exhibit a moisturizing effect of 25 to 48% and an exfoliation effect of 70% or more.
이하, 실시예 및 실험예를 통해 보다 구체적으로 본 발명을 설명하도록 한다.Hereinafter, the present invention will be described in more detail through examples and experimental examples.
(제조예)(Manufacture example)
제조예 1: 울금 추출물의 제조Preparation Example 1: Preparation of turmeric extract
건조된 울금 60 kg과 정제수 200 L를 혼합하고, 수증기 증류법을 이용하여 울금 추출물을 제조한 후 유성 성분(원료화 되지 않은 오일)과 수성성분(원료화 되지 않은 뿌리수)으로 분리하였다.After mixing 60 kg of dried turmeric and 200 L of purified water, and preparing a turmeric extract using steam distillation, it was separated into an oil component (non-raw oil) and an aqueous component (non-raw water root).
제조예 2:울금 오일의 제조Production Example 2: Production of turmeric oil
제조예 1에서 분리된 유성 성분 2 중량%, 글리세린(Glycerin) 66 중량%, 디메티콘(Diemethicone) 18 중량% 수첨 레시틴(Hydrogenated lecithin) 4 중량% 및 증류수 10 중량%를 75 ℃의 온도에서 혼합하여 혼합물을 제조하였다.2% by weight of the oil component separated in Preparation Example 1, 66% by weight of glycerin, 18% by weight of dimethicone, 4% by weight of hydrogenated lecithin, and 10% by weight of distilled water were mixed at a temperature of 75 ° C. A mixture was prepared.
마지막으로, 상기 혼합물을 200 mesh로 여과한 후 1,500 bar의 고압 균질기를 이용하여 균질화하여 울금 오일을 제조하였다.Finally, the mixture was filtered through 200 mesh and then homogenized using a high-pressure homogenizer at 1,500 bar to prepare turmeric oil.
제조예 3: 울금 뿌리수의 제조Preparation Example 3: Preparation of turmeric root water
제조예 1에서 분리된 수성성분 88 중량%, 1,3 부틸렌 글리콜(Butylene Glycol) 10 중량% 및 1,2 헥산디올(Hexanediol) 2 중량%를 혼합하여 혼합액 제조한 후 0.1N NaCl을 이용하여 pH를 보정하였다.88% by weight of the aqueous component separated in Preparation Example 1, 10% by weight of 1,3 Butylene Glycol and 2% by weight of 1,2 Hexanediol were mixed to prepare a mixed solution, and then using 0.1N NaCl pH was calibrated.
마지막으로, 제균기(0.45 ㎛)를 이용하여 혼합액을 제균하여 원료화된 울금 뿌리수를 제조하였다.Finally, the mixture was sterilized using a sterilizer (0.45 μm) to prepare raw turmeric root water.
(실시예)(Example)
실시예 1: 바디클렌저용 화장료 조성물 제조 1Example 1: Preparation of cosmetic composition for body cleanser 1
정제수 62.87 중량%, 소듐C14-16올레핀설포네이트(Sodium C14-16 olefin sulfonate) 16 중량%, 울금 뿌리 추출물 4 중량% 코코-베타인(Coco-betaine) 4 중량%, 글리세린(Glycerin) 3 중량%, 소듐클로라이드(Sodium chloride) 2 중량%, 부틸렌글라이콜(Butylene glycol) 2 중량%, 글라이콜다이스테아레이트(Glycol distearate) 1 중량%, 다이소듐라우레스설포석시네이트(Disodium laureth sulfosuccinate) 1 중량%, 우레아(Urea) 0.5 중량%, 하이드록시아세토페논(Hydroxyacetophenone) 0.5 중량%, 테트라데센(Tetradecene) 0.37 중량%, 라우릴베타인(Lauryl betaine) 0.5 중량%, 헥사데센(Hexadecene) 0.25 중량%, 1,2-헥사다이올(1,2-Hexanediol) 0.2 중량%, 시트릭애씨드(Citri acid) 0.3 중량%, 울금 분말 0.2 중량%, 베타인(Betaine) 0.1 중량%, 소듐벤조에이트(Sodium benzoate) 0.1 중량%, 티트리추출물(Melaleuca alternifolia extract) 0.1 중량%, 프로폴리스추출물(Propolis extract) 0.05 중량%, 다이메디콘(Dimethicone) 0.05 중량%, 소듐하이알루로네이트(Sodium hyaluronate) 0.05 중량%, 하이드로제네이티드레시틴(Hydrogenated lecithin) 0.01 중량% 및 향료(Fragrance) 0.85 중량%로 이루어진 바디클렌저용 화장료 조성물을 통상의 방법에 따라 제조하였다.Purified water 62.87% by weight, sodium C14-16 olefin sulfonate 16% by weight, turmeric root extract 4% by weight Coco-betaine 4% by weight, glycerin 3% by weight ,
비교예 1Comparative Example 1
실시예 1과 동일하게 제조하되, 울금 분말 0.2 중량%, 울금 뿌리수 추출물 4 중량% 및 정제수 62.87 중량% 대신에 울금 분말 0.1 중량%, 울금 뿌리수 추출물 4 중량% 및 정제수 62.97 중량%를 투입하여 화장료 조성물을 제조하였다.It was prepared in the same manner as in Example 1, but instead of 0.2% by weight of turmeric powder, 4% by weight of turmeric root extract, and 62.87% by weight of purified water, 0.1% by weight of turmeric powder, 4% by weight of turmeric root extract, and 62.97% by weight of purified water were added. A cosmetic composition was prepared.
비교예 2Comparative Example 2
실시예 1과 동일하게 제조하되, 울금 분말 0.2 중량%, 울금 뿌리수 추출물 4 중량% 및 정제수 62.87 중량% 대신에 울금 분말 0.1 중량%, 울금 뿌리수 추출물 6 중량% 및 정제수 60.97 중량%를 투입하여 화장료 조성물을 제조하였다.It was prepared in the same manner as in Example 1, but instead of 0.2% by weight of turmeric powder, 4% by weight of turmeric root extract, and 62.87% by weight of purified water, 0.1% by weight of turmeric powder, 6% by weight of turmeric root extract, and 60.97% by weight of purified water were added. A cosmetic composition was prepared.
비교예 3Comparative Example 3
실시예 1과 동일하게 제조하되, 울금 분말 0.2 중량%, 울금 뿌리수 추출물 4 중량% 및 정제수 62.87 중량% 대신에 울금 분말 0.2 중량%, 울금 뿌리수 추출물 6 중량% 및 정제수 60.87 중량%를 투입하여 화장료 조성물을 제조하였다.It was prepared in the same manner as in Example 1, but instead of 0.2% by weight of turmeric powder, 4% by weight of turmeric root extract, and 62.87% by weight of purified water, 0.2% by weight of turmeric powder, 6% by weight of turmeric root extract, and 60.87% by weight of purified water were added, A cosmetic composition was prepared.
(실험예)(experimental example)
실험예 1: 관능평가Experimental Example 1: Sensory evaluation
실시예 및 비교예들의 선호도 조사를 실시하였다.A preference survey of Examples and Comparative Examples was conducted.
상기 선호도 조사는 7 점 척도로 만족도 조사를 실시하였고 향, 촉감, 색 및 전반적 기호도를 조사하여 하기의 표 1에 나타내었다.The preference survey was conducted on a 7-point scale, and the flavor, touch, color, and overall preference were investigated and shown in Table 1 below.
상기 표 1에서 확인할 수 있듯이, 비교예 2 및 실시예에서 울금 향을 강하게 감지하였으며 촉감이 좋은 것으로 평가되었다. 그러나, 색감과 전반적 기호도 측면을 고려하였을 때 본 발명의 실시예가 가장 높은 기호도를 나타내는 것을 확인할 수 있다.As can be seen in Table 1, in Comparative Example 2 and Example, the turmeric flavor was strongly detected and the tactile sensation was evaluated as good. However, it can be confirmed that the embodiment of the present invention shows the highest preference when the color and overall preference aspects are considered.
실험예 2: 안전성 평가Experimental Example 2: Safety evaluation
본 발명의 바디클렌저용 화장료 조성물(실시예)의 안정성평가를 위해 피험자 33명을 대상으로 피부첩포시험을 실시하였으며, 그 결과를 하기의 표 2에 나타내었다.To evaluate the stability of the cosmetic composition for body cleanser (Example) of the present invention, a skin patch test was conducted on 33 subjects, and the results are shown in Table 2 below.
*반응도 0.00~0.75 무자극; 0.76~1.50 미자극; 1.51~2.50 경자극; 2.51~4.00 중자극; 4.01 강자극* Responsiveness 0.00~0.75 non-irritating; 0.76-1.50 not irritant; 1.51-2.50 mild irritation; 2.51 to 4.00 moderate irritation; 4.01 strong stimulation
상기 표 2에서 확인할 수 있듯이, 바디클렌저용 화장료 조성물의 첩포 제거 후 30 분, 24 시간 경과 후에 자극이 관찰되지 않았고, 48 시간 경과 후에는 ±자극(국제접촉피부염연구회 판정기준, 미자극)이 3 명 관찰되었으며, 평균 피부반응도는 0.51로 판정기준에 따라 무자극인 것을 확인할 수 있다.As can be seen in Table 2 above, irritation was not observed after 30 minutes and 24 hours after removing the patch of the cosmetic composition for body cleanser, and after 48 hours ± irritation (international contact dermatitis research society criterion, non-irritation) was 3 was observed, and the average skin reactivity was 0.51, which confirmed that it was non-irritating according to the criterion.
하기의 표 3은 국제접촉피부염연구회의 판정기준을 나타낸 것이다.Table 3 below shows the criteria for international contact dermatitis research.
실험예 3: 피부 보습 평가Experimental Example 3: Evaluation of skin moisturizing
본 발명에 따른 바디클렌저용 화장료 조성물의 피부보습 평가를 실시하였다.Skin moisturizing evaluation of the cosmetic composition for body cleanser according to the present invention was conducted.
평가는 Epslion E100을 이용하여 평가하였으며, 그 결과를 도 2에 나타내었다.Evaluation was evaluated using Epslion E100, and the results are shown in FIG. 2 .
도 2A 및 도 2B는 바디클렌저용 화장료 조성물을 사용한 후 피부 수분 변화 및 피부 수분 개선율을 나타낸 것이다.2A and 2B show changes in skin moisture and improvement in skin moisture after using a cosmetic composition for body cleanser.
도 2을 참조하면, Epslion E100을 이용하여 왼쪽 전완부위의 피부 보습 개선도를 분석한 결과, 피부 수분이 바디클렌저용 화장료 조성물 사용 전과 비교하여 1 회 사용직후 48.74 %, 2 주 사용 후 25.65 % 증가하는 변화를 나타내었다. 또한 바디클렌저용 화장료 조성물 사용 전과 비교하여 1 회 사용 직후, 2 주 사용 후 통계적으로 유의하게 나타나(p<0.001) 본 발명의 바디클렌저용 화장료 조성물이 피부 보습 개선에 효과가 있는 것을 확인할 수 있다.Referring to FIG. 2, as a result of analyzing the improvement in skin moisturization of the left forearm using Epslion E100, the skin moisture increased by 48.74% immediately after one use and by 25.65% after two weeks of use compared to before using the cosmetic composition for body cleanser. showed a change in In addition, compared to before using the cosmetic composition for body cleanser, it was found to be statistically significant immediately after use and after 2 weeks of use (p<0.001), indicating that the cosmetic composition for body cleanser of the present invention is effective in improving skin moisturizing.
실험예 4: 각질제거 및 세정효과 분석Experimental Example 4: Analysis of dead skin removal and cleaning effect
비디오 마이크로 스코프와 이미지 분석프로그램을 이용하여 실시예의 각질 세정효과를 평가하였다.The keratin cleansing effect of the examples was evaluated using a video microscope and an image analysis program.
본 발명에 따른 바디클렌저용 화장료 조성물 사용 전과 1회 사용 직후, 2주 사용 후의 각질 세정효과를 평가한 결과는 도 3에 나타내었다.The results of evaluating the keratin cleansing effect before using the cosmetic composition for body cleanser according to the present invention, immediately after using once, and after using for 2 weeks are shown in FIG. 3 .
도 3A 내지 도 3E는 바디클렌저용 화장료 조성물의 사용후 피부 각질도 변화 및 개선도를 나타낸 것이다.Figures 3A to 3E show the change and improvement of skin keratinization after use of the cosmetic composition for body cleanser.
도 3를 참조하여, 바디클렌저용 화장료 조성물 사용전 피부 각질도를 비교하여 보면 1 회 사용 직후 58.87 %, 2 주 사용 후 68.51 %가 감소되는 것을 확인할 수 있다. 또한, 바디클렌저용 화장료 조성물 사용 전과 비교하여 1 회 사용 직후, 2 주 사용 후 통계적으로 유의하게 나타나(p<0.001) 실시예가 각질 세정효과에 도움을 주는 것을 확인할 수 있다.Referring to FIG. 3, when comparing the skin keratinization before using the cosmetic composition for body cleanser, it can be seen that 58.87% immediately after one use and 68.51% after two weeks of use. In addition, compared to before using the cosmetic composition for body cleanser, it was found to be statistically significant immediately after use once and after use for 2 weeks (p<0.001), confirming that the example helps the keratin cleansing effect.
실험예 5: 사용감 및 피부상태 설문 조사Experimental Example 5: Feeling of use and skin condition survey
본 발명에 따른 바디클렌저용 화장료 조성물의 사용감 및 피부상태에 대한 설문 조사를 실시하였다.A survey was conducted on the feeling of use and skin condition of the cosmetic composition for body cleanser according to the present invention.
본 발명의 바디클렌저용 화장료 조성물을 사용한 피시험자는 사용 후 알레르기성 접촉 피부염이나 자극성 접촉 피부염에 대한 이상반응은 관찰되지 않았다. 또한, 피시험자를 대상으로 한 설문조사에서도 특별한 피부이상반응은 관찰되지 않았다(data not shown). 피시험자의 바디클렌저용 화장료 조성물 사용 후 사용감 및 피부상태를 설문조사를 실시하여 하기의 표 4 및 표 5에 나타내었다. No adverse reactions to allergic contact dermatitis or irritant contact dermatitis were observed after use of the test subject who used the cosmetic composition for body cleanser of the present invention. In addition, no particular skin adverse reaction was observed in the questionnaire survey targeting test subjects (data not shown). After using the cosmetic composition for body cleanser of the test subject, a survey was conducted on the feeling of use and skin condition, and the results are shown in Tables 4 and 5 below.
사용감 조사는 만족/불만족 양자택일형을 이용하여 세정력, 촉촉함, 매끈함, 만족도 항목에 대해 피시험자의 시험물질에 대한 사용감을 설문조사하였다.The feeling of use survey was conducted using a satisfaction / dissatisfaction alternative type to survey the subject's feeling of use for the test substance for detergency, moistness, smoothness, and satisfaction items.
상기 표 4 및 표 5를 참조하면, 전체 항목에 대해 만족한다는 답변이 우세하였으며, 피부 상태에 대해서도 전반적으로 긍정적인 결과를 얻었다.Referring to Tables 4 and 5, the majority of the answers were satisfactory for all items, and overall positive results were obtained for skin conditions.
따라서, 본 발명의 울금을 포함하는 바디클렌저용 화장료 조성물을 이용하면, 울금의 유효성분을 포함함으로써, 피부 세정시 각질제거 효과를 갖는 것은 물론, 노화방지 효과 및 피지선 안정화가 지속적으로 도모되어 피부 보습력을 향상시킬 수 있다.Therefore, when the cosmetic composition for body cleanser containing turmeric of the present invention is used, by including the active ingredient of turmeric, it has an exfoliating effect during skin cleansing, as well as an anti-aging effect and sebaceous gland stabilization, which continuously promotes skin moisturizing power. can improve
제형예: 바디클렌저 화장료 조성물Formulation Example: Body Cleanser Cosmetic Composition
정제수 62.3873 중량%, 소듐C14-16올레핀설포네이트(Sodium C14-16 olefin sulfonate) 16 중량%, 울금 뿌리 추출물 4.5825 중량% 코코-베타인(Coco-betaine) 4 중량%, 글리세린(Glycerin) 3 중량%, 소듐클로라이드(Sodium chloride) 2 중량%, 부틸렌글라이콜(Butylene glycol) 2 중량%, 글라이콜다이스테아레이트(Glycol distearate) 1 중량%, 다이소듐라우레스설포석시네이트(Disodium laureth sulfosuccinate) 1 중량%, 우레아(Urea) 0.5 중량%, 하이드록시아세토페논(Hydroxyacetophenone) 0.5 중량%, 테트라데센(Tetradecene) 0.37 중량%, 라우릴베타인(Lauryl betaine) 0.5 중량%, 헥사데센(Hexadecene) 0.25 중량%, 1,2-헥사다이올(1,2-Hexanediol) 0.2 중량%, 시트릭애씨드(Citri acid) 0.3 중량%, 울금 뿌리 분말 0.1 중량%, 베타인(Betaine) 0.1 중량%, 소듐벤조에이트(Sodium benzoate) 0.1 중량%, 티트리추출물(Melaleuca alternifolia extract) 0.1 중량%, 프로폴리스추출물(Propolis extract) 0.05 중량%, 다이메디콘(Dimethicone) 0.05 중량%, 소듐하이알루로네이트(Sodium hyaluronate) 0.05 중량%, 하이드로제네이티드레시틴(Hydrogenated lecithin) 0.01 중량%, 울금 뿌리 오일 0.0002 중량% 및 향료(Fragrance) 0.85 중량%로 이루어진 바디클렌저용 화장료 조성물을 통상의 방법에 따라 제조하였다.Purified water 62.3873% by weight, sodium C14-16 olefin sulfonate 16% by weight, turmeric root extract 4.5825% by weight Coco-betaine 4% by weight, glycerin 3% by weight ,
이상, 본 발명을 바람직한 실시예를 사용하여 상세히 설명하였으나, 본 발명의 범위는 특정 실시예에 한정되는 것은 아니며, 첨부된 특허청구범위에 의하여 해석되어야 할 것이다. 또한, 이 기술분야에서 통상의 지식을 습득한 자라면, 본 발명의 범위에서 벗어나지 않으면서도 많은 수정과 변형이 가능함을 이해하여야 할 것이다.In the above, the present invention has been described in detail using preferred embodiments, but the scope of the present invention is not limited to specific embodiments, and should be interpreted according to the appended claims. In addition, those skilled in the art should understand that many modifications and variations are possible without departing from the scope of the present invention.
Claims (6)
바디클렌저용 화장료 조성물.containing turmeric,
Cosmetic composition for body cleanser.
상기 울금은,
울금 분말 및 울금 뿌리수인 것을 특징으로 하는,
바디클렌저용 화장료 조성물.According to claim 1,
The turmeric,
Characterized in that it is turmeric powder and turmeric root water,
Cosmetic composition for body cleanser.
상기 조성물은,
전체 조성물 100 중량%를 기준으로,
울금 분말 0.15~0.25 중량% 및 울금 뿌리수 3~5 중량%를 포함하는 것을 특징으로 하는,
바디클렌저용 화장료 조성물.According to claim 2,
The composition,
Based on 100% by weight of the total composition,
Characterized in that it contains 0.15 to 0.25% by weight of turmeric powder and 3 to 5% by weight of turmeric root water,
Cosmetic composition for body cleanser.
상기 울금 뿌리수는,
용매추출(Solvent extraction), 증류(Hydrodistillation) 및 수증기 증류(Steam distillation) 중 선택된 어느 하나의 방법으로 추출한 후 분리하여 수득된 것임을 특징으로 하는,
바디클렌저용 화장료 조성물.According to claim 2,
The turmeric root water,
Characterized in that it is obtained by separation after extraction by any one method selected from solvent extraction, distillation, and steam distillation,
Cosmetic composition for body cleanser.
상기 울금 뿌리수는,
수증기 증류법으로 제조된 것임을 특징으로 하는,
바디클렌저용 화장료 조성물.According to claim 2,
The turmeric root water,
Characterized in that it is produced by steam distillation,
Cosmetic composition for body cleanser.
상기 조성물은,
25~48 %의 수분 증진 및 70 % 이상의 각질 제거효과를 발휘하는 것을 특징으로 하는,
바디클렌저용 화장료 조성물.According to claim 1,
The composition,
Characterized in that it exhibits a moisture enhancement of 25 to 48% and an exfoliation effect of more than 70%,
Cosmetic composition for body cleanser.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210077405A KR102601369B1 (en) | 2021-06-15 | 2021-06-15 | Cosmetic composition for body cleanser containing turmeric |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210077405A KR102601369B1 (en) | 2021-06-15 | 2021-06-15 | Cosmetic composition for body cleanser containing turmeric |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220168214A true KR20220168214A (en) | 2022-12-23 |
KR102601369B1 KR102601369B1 (en) | 2023-11-14 |
Family
ID=84536324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210077405A KR102601369B1 (en) | 2021-06-15 | 2021-06-15 | Cosmetic composition for body cleanser containing turmeric |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102601369B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102648658B1 (en) * | 2024-01-04 | 2024-03-19 | 주식회사 제이에스뷰티 | Body wash using egg yolk oil with anti-aging effect |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040081248A (en) * | 2003-03-14 | 2004-09-21 | (주)에코텍 | Preparation method of functional bath material containing Curcuma longa L. |
JP2011016767A (en) * | 2009-07-10 | 2011-01-27 | Mukogawa Gakuin | Moisturizer |
KR101655222B1 (en) | 2014-07-07 | 2016-09-07 | 경동대학교 산학협력단 | cleansing cosmetic using Lonicera japonica, Rosa multiflora and deep seewater |
KR102228257B1 (en) * | 2020-06-17 | 2021-03-16 | (주)대한뷰티산업진흥원 | Composition for anti-inflammation or anti-acne comprising extract of Immature Citrus Fruit, Curcuma longa and citrus blossom honey |
-
2021
- 2021-06-15 KR KR1020210077405A patent/KR102601369B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040081248A (en) * | 2003-03-14 | 2004-09-21 | (주)에코텍 | Preparation method of functional bath material containing Curcuma longa L. |
JP2011016767A (en) * | 2009-07-10 | 2011-01-27 | Mukogawa Gakuin | Moisturizer |
KR101655222B1 (en) | 2014-07-07 | 2016-09-07 | 경동대학교 산학협력단 | cleansing cosmetic using Lonicera japonica, Rosa multiflora and deep seewater |
KR102228257B1 (en) * | 2020-06-17 | 2021-03-16 | (주)대한뷰티산업진흥원 | Composition for anti-inflammation or anti-acne comprising extract of Immature Citrus Fruit, Curcuma longa and citrus blossom honey |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102648658B1 (en) * | 2024-01-04 | 2024-03-19 | 주식회사 제이에스뷰티 | Body wash using egg yolk oil with anti-aging effect |
Also Published As
Publication number | Publication date |
---|---|
KR102601369B1 (en) | 2023-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101125893B1 (en) | Medicinal herb cosmetic soap composition | |
JP4976636B2 (en) | Antipruritic composition and composition for promoting wound healing | |
US6485711B1 (en) | Organic toothpaste containing saponin | |
EP2470271A2 (en) | Abrasive agent based on natural raw ingredients, having properties improving rheology | |
KR102226774B1 (en) | Detergent comprising the extract of astragalus membranaceus, polydonati rhizoma and pine leaf, and the method of manufacturing thereof | |
KR102601369B1 (en) | Cosmetic composition for body cleanser containing turmeric | |
KR101272375B1 (en) | Soap composition containing black ginseng extract | |
US8075901B1 (en) | Cosmetic formulation | |
CN108451818A (en) | A kind of elm bark extracting solution and its preparation method and application | |
CN104928081A (en) | Horse oil and plant composition for inhibiting and removing mites and use of horse oil and plant composition in soap making | |
KR20210091576A (en) | Method for Manufacturing All-in-One Product Combined Bodywash with Shampoo for reinforcing Body Odor Removal | |
KR20130113757A (en) | Soap comprising wood-cultivated ginseng and manufacturing method thereof | |
KR20200123672A (en) | A nutural herbal medicnes composition for anti hair loss and hair restoration and method of making it and cleaner used it | |
KR101045410B1 (en) | A cosmetic composition using olive oil and a manufacturing method thereof | |
JP7316666B2 (en) | Cleansing composition and method for producing same | |
KR102027681B1 (en) | Cosmetic ingredients using plum distillation extract, and Its manufacturing method | |
KR20010103094A (en) | Soap having a fruit's extraction of maximowiczia typica and method thereof | |
KR100970743B1 (en) | Method of Manufacturing Natural Tocopherol Soap and Soap Making Thereof | |
JP5154768B2 (en) | Tsubakiceramide extraction method and skin / hair cosmetics | |
KR102694804B1 (en) | moisturizing soap compositions | |
KR102329748B1 (en) | Wax-type cleanser improving problematic skin | |
KR102293585B1 (en) | Wax-type cleanser | |
KR101232755B1 (en) | Soap composition comprising bamboo-kaolin and manufacturing method for thereof | |
KR102003717B1 (en) | Composition for the improvement in the smell of thearmpit | |
JP2005206588A (en) | Skin external preparation for preventing acne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |